BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Negar Khoshghamat, Niloufar Jafari, Vajiheh Toloue-pouya, Shakiba Azami, Seyyedeh Helya Mirnourbakhsh, Majid Khazaei, Gordon A. Ferns, Majid Rajabian, Amir Avan. The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancerLife Sciences 2021; 270: 119118 doi: 10.1016/j.lfs.2021.119118
2
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Adenocarcinoma ductal de páncreas. Experiencia de 11 años en un centro de tercer nivelRevista de Gastroenterología de México 2021; 86(2): 118 doi: 10.1016/j.rgmx.2020.04.004
3
Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti. BRCA in Gastrointestinal Cancers: Current Treatments and Future PerspectivesCancers 2020; 12(11): 3346 doi: 10.3390/cancers12113346
4
M.-P. Vullierme, M. Lagadec. Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ?Journal de Radiologie Diagnostique et Interventionnelle 2016; 97(5): 509 doi: 10.1016/j.jradio.2016.10.003
5
Alexandra R Lewis, Juan W Valle, Mairead G McNamara. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?World Journal of Gastroenterology 2016; 22(32): 7175-7185 doi: 10.3748/wjg.v22.i32.7175
6
Penpa Dorjee, Zi-Wen Long. A mixed treatment comparison of toxicity of gemcitabine combined with different targeted drugs in the treatment of advanced or metastatic pancreatic cancerCancer Biology & Therapy 2018; 19(6): 497 doi: 10.1080/15384047.2018.1433503
7
Divyanshoo R. Kohli, Ken Robert Smith, Jathine Wong, Zhe Yu, Kenneth Boucher, Douglas O. Faigel, Rahul Pannala, Randall W. Burt, Karen Curtin, N. Jewel Samadder. Familial pancreatic cancer risk: a population-based study in UtahJournal of Gastroenterology 2019; 54(12): 1106 doi: 10.1007/s00535-019-01597-3
8
Wataru Gonoi, Takana Yamakawa Hayashi, Hidemi Okuma, Masaaki Akahane, Yousuke Nakai, Suguru Mizuno, Ryosuke Tateishi, Hiroyuki Isayama, Kazuhiko Koike, Kuni Ohtomo. Development of pancreatic cancer is predictable well in advance using contrast-enhanced CT: a case–cohort studyEuropean Radiology 2017; 27(12): 4941 doi: 10.1007/s00330-017-4895-8
9
Ji Kon Ryu. The Early Detection of Pancreatic Cancer: Whom and How?Korean Journal of Pancreas and Biliary Tract 2015; 20(4): 198 doi: 10.15279/kpba.2015.20.4.198
10
Tanya Dwarte, Skye McKay, Amber Johns, Katherine Tucker, Allan D. Spigelman, David Williams, Alina Stoita. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening programHereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0129-1
11
Thomas Hank, Oliver Strobel. Conversion Surgery for Advanced Pancreatic CancerJournal of Clinical Medicine 2019; 8(11): 1945 doi: 10.3390/jcm8111945
12
Akihiro Ohmoto, Shinichi Yachida, Chigusa Morizane. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic CancerInternational Journal of Molecular Sciences 2019; 20(3): 561 doi: 10.3390/ijms20030561
13
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care2019; : 1 doi: 10.1007/978-3-319-74698-2_180-1
14
Elena M. Stoffel, Shannon E. McKernin, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion SummaryJournal of Oncology Practice 2019; 15(2): 108 doi: 10.1200/JOP.18.00629
15
Griffin McNamara, Karla Ali, Shraddha Vyas, Tri Huynh, Monica Nyland, Deanna Almanza, Christine Laronga, Jason Klapman, Jennifer Permuth. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer CenterGastrointestinal Disorders 2018; 1(1): 106 doi: 10.3390/gidisord1010008
16
Priyanka Jha, Benjamin M. Yeh, Ronald Zagoria, Eric Collisson, Zhen J. Wang. The Role of MR Imaging in Pancreatic CancerMagnetic Resonance Imaging Clinics of North America 2018; 26(3): 363 doi: 10.1016/j.mric.2018.03.004
17
Juan E. Corral, Karl F. Mareth, Douglas L. Riegert-Johnson, Ananya Das, Michael B. Wallace. Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort StudiesClinical Gastroenterology and Hepatology 2019; 17(1): 41 doi: 10.1016/j.cgh.2018.04.065
18
Akiko Kowada. Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in JapanPancreas 2020; 49(8): 1052 doi: 10.1097/MPA.0000000000001614
19
M.-P. Vullierme, M. Lagadec. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?Diagnostic and Interventional Imaging 2016; 97(12): 1233 doi: 10.1016/j.diii.2016.08.018
20
Uwe Pelzer. Pankreaskarzinom – Therapiestandards und spezielle Situationenbest practice onkologie 2018; 13(5): 238 doi: 10.1007/s11654-018-0098-2
21
R. S. O’Neill, B. Meiser, S. Emmanuel, D. B. Williams, A. Stoita. Long-term positive psychological outcomes in an Australian pancreatic cancer screening programFamilial Cancer 2020; 19(1): 23 doi: 10.1007/s10689-019-00147-3
22
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care2020; : 1809 doi: 10.1007/978-3-319-74588-6_180
23
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomesWorld Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
24
Sung Bum Kim. Model to Stratify Risk of Pancreatic Cancer in Patients Diagnosed as New-onset DiabetesThe Korean Journal of Gastroenterology 2018; 72(3): 159 doi: 10.4166/kjg.2018.72.3.159
25
Lauren Fried, Andrea Tan, Shirin Bajaj, Tracey N. Liebman, David Polsky, Jennifer A. Stein. Technological advances for the detection of melanomaJournal of the American Academy of Dermatology 2020; 83(4): 996 doi: 10.1016/j.jaad.2020.03.122
26
Julia Benzel, Volker Fendrich. Familial Pancreatic CancerOncology Research and Treatment 2018; 41(10): 611 doi: 10.1159/000493473
27
Ankit Chhoda, Lingeng Lu, Barbara M. Clerkin, Harvey Risch, James J. Farrell. Current Approaches to Pancreatic Cancer ScreeningThe American Journal of Pathology 2019; 189(1): 22 doi: 10.1016/j.ajpath.2018.09.013
28
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic CancerInternational Journal of Molecular Sciences 2021; 22(5): 2655 doi: 10.3390/ijms22052655
29
Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff. Pancreatic cancerThe Lancet 2020; 395(10242): 2008 doi: 10.1016/S0140-6736(20)30974-0
30
Elisabeth King, Bita Nehoray. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk FamiliesClinical Journal of Oncology Nursing 2019; 23(6): 579 doi: 10.1188/19.CJON.579-582
31
Chris M. Lindquist, Frank H. Miller, Nancy A. Hammond, Paul Nikolaidis. Pancreatic cancer screeningAbdominal Radiology 2018; 43(2): 264 doi: 10.1007/s00261-017-1308-z
32
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Pancreatic ductal adenocarcinoma: Eleven years of experience at a tertiary care hospital centerRevista de Gastroenterología de México (English Edition) 2021; 86(2): 118 doi: 10.1016/j.rgmxen.2020.04.005
33
Juan E. Corral, Ananya Das, Marco J. Bruno, Michael B. Wallace. Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk IndividualsPancreas 2019; 48(4): 526 doi: 10.1097/MPA.0000000000001268
34
Kjetil Søreide. Textbook of Pancreatic Cancer2021; : 339 doi: 10.1007/978-3-030-53786-9_23
35
R. Vera, A. Ferrández, C. J. Ferrer, C. Flores, C. Joaquín, S. López, T. Martín, E. Martín, M. Marzo, A. Sarrión, E. Vaquero, A. Zapatero, J. Aparicio. Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societiesClinical and Translational Oncology 2017; 19(7): 834 doi: 10.1007/s12094-016-1609-7
36
Amr F. Mourad, Mona M. Sayed, Hussein Fakhry. Is magnetic resonance diffusion-weighted imaging superior in the diagnosis of pancreatic adenocarcinoma and does it have a prognostic value?The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(4): 908 doi: 10.1016/j.ejrnm.2018.06.001
37
Elena M. Stoffel, Shannon E. McKernin, Randall Brand, Marcia Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M. Petersen, Diane M. Simeone, Matthew Yurgelun, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical OpinionJournal of Clinical Oncology 2019; 37(2): 153 doi: 10.1200/JCO.18.01489
38
Louis de Mestier, Jean-Baptiste Danset, Cindy Neuzillet, Vinciane Rebours, Jérôme Cros, Nadem Soufir, Pascal Hammel. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriersEndocrine-Related Cancer 2016; 23(10): T57 doi: 10.1530/ERC-16-0269
39
Louis Mestier, Marie Muller, Jérôme Cros, Marie-Pierre Vullierme, Dewi Vernerey, Frédérique Maire, Safi Dokmak, Vinciane Rebours, Alain Sauvanet, Philippe Lévy, Pascal Hammel. Appropriateness of pancreatic resection in high‐risk individuals for familial pancreatic ductal adenocarcinoma: a patient‐level meta‐analysis and proposition of the Beaujon scoreUnited European Gastroenterology Journal 2019; 7(3): 358 doi: 10.1177/2050640618824910